Biocryst Pharmaceuticals (BCRX) Prepaid Assets (2010 - 2026)

Biocryst Pharmaceuticals (BCRX) has 17 years of Prepaid Assets data on file, last reported at $19.1 million in Q1 2026.

• Quarterly Prepaid Assets rose 33.41% year-over-year to $19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.1 million (up 33.41% YoY) and the FY2025 annual result came in at $17.2 million, up 24.94% from the prior year.
• Prepaid Assets advanced to $19.1 million in Q1 2026, from $17.2 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $20.0 million in Q3 2023 to a low of $11.1 million in Q2 2022.
• A 5-year average of $15.3 million and a median of $15.2 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 108.75% — and 2024, when it declined 29.63%.
• Tracing BCRX's Prepaid Assets over 5 years: stood at $12.6 million in 2022, then soared by 55.27% to $19.5 million in 2023, then decreased by 29.63% to $13.8 million in 2024, then rose by 24.94% to $17.2 million in 2025, then increased by 11.24% to $19.1 million in 2026.
• The last three Prepaid Assets figures came in at $19.1 million (Q1 2026), $17.2 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.